Key Finding
Acupoint application therapy at Shenque (CV8) combined with probiotics achieved an 88.1% effectiveness rate for IBS-D compared to 73.8% with probiotics alone, with significant improvements in diarrhea, abdominal pain, and bloating.
Researchers in China studied whether acupuncture point patches applied to the abdomen could help people with irritable bowel syndrome (IBS) who experience primarily diarrhea. This study included 88 patients diagnosed with IBS-D according to traditional Chinese medicine patterns of spleen deficiency and dampness retention. Patients were divided into two groups: one received standard probiotic treatment (Bifidobacterium capsules twice daily), while the other received the same probiotics plus an herbal patch applied to an acupuncture point called Shenque (CV8), located at the navel, for 12 hours daily. Both groups received treatment for 28 days. The results showed that both groups improved, but patients who received the acupuncture point patches experienced significantly better outcomes. The combination therapy group had an 88% effectiveness rate compared to 74% in the probiotic-only group. Patients receiving the patches reported greater improvements in diarrhea, abdominal pain, bloating, and stool quality. Their overall IBS severity scores and quality of life measures also improved more substantially. The treatment was found to be safe with no serious side effects reported. This suggests that acupuncture point application therapy may be a valuable addition to standard treatment for IBS-D, particularly for patients whose symptoms align with the traditional Chinese medicine pattern studied. If you're considering acupuncture for digestive issues, consult with a licensed acupuncturist who has experience treating gastrointestinal conditions.
This randomized controlled trial evaluated acupoint application therapy at Shenque (CV8) for diarrhea-predominant IBS with spleen deficiency and dampness retention pattern. Eighty-four patients completed the 4-week study (42 per group). The experimental group received Bifidobacterium triple active bacteria capsules (0.48g bid) plus herbal patches applied to CV8 for 12 hours daily, while controls received probiotics alone. The combination therapy group demonstrated statistically significant improvements in TCM syndrome scores, IBS-SSS scores, and IBS-DSQ scores compared to controls (P<0.01 to P<0.001). Specific symptom improvements included diarrhea, abdominal pain, and abdominal distension (P<0.01, P<0.05). Total effectiveness rate was 88.1% in the experimental group versus 73.8% in controls (P<0.05). No significant differences were observed in fatigue or anorexia scores. Clinical takeaway: Acupoint application at CV8 combined with probiotics provides superior symptomatic relief for spleen-deficient, dampness-retention pattern IBS-D compared to probiotics alone, representing a safe adjunctive treatment option.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 12-week randomized controlled trial is underway to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS) can reduce body weight in patients with obesity by modulating the microbiota-gut-brain axis, assessed through fMRI, gut microbiota profiling, and serum brain-gut peptides.
📌 Acupuncture significantly reduced chronic urticaria activity scores and improved dermatology-related quality of life compared to sham acupuncture and waitlist control, performing comparably to Western medicine for symptom control.
📌 77.6% of women with moderate-to-severe menopausal symptoms experienced a clinically relevant reduction in symptoms following a standardized acupuncture protocol, with vocational education level being the most consistent predictor of treatment response.